Common Contracts
18 similar Securities Purchase Agreement contracts by CareDx, Inc., Silicom LTD, Threshold Pharmaceuticals Inc, others
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 15th, 2016 • CareDx, Inc. • Services-medical laboratories • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 15, 2016, by and among CareDx, Inc., a Delaware corporation with headquarters located at 3260 Bayshore Boulevard, Brisbane, California 94005 (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 14th, 2016 • CareDx, Inc. • Services-medical laboratories • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 12, 2016, by and among CareDx, Inc., a Delaware corporation with headquarters located at 3260 Bayshore Boulevard, Brisbane, California 94005 (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 2nd, 2015 • GRANDPARENTS.COM, Inc. • Services-computer processing & data preparation • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 29, 2015, by and among GRANDPARENTS.COM, INC., a Delaware corporation with headquarters located at 589 Eighth Avenue, 6th Floor, New York, New York 10018 (the “Company”), and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”). Any Investor who shall be party to this Agreement shall be subject to the prior approval of the Company in its sole discretion.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 31st, 2014 • Regado Biosciences Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 31, 2014, by and among Regado Biosciences, Inc., a Delaware corporation with headquarters located at 120 Mountain View Boulevard, Basking Ridge, New Jersey 07920 (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 28th, 2014 • Alimera Sciences Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 27, 2014, by and among Alimera Sciences, Inc., a Delaware corporation with headquarters located at 6120 Windward Parkway, Suite 290, Alpharetta, GA 30005 (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2013 • dELiAs, Inc. • Retail-catalog & mail-order houses • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of July 25, 2013, by and among dELiA*s, Inc., a Delaware corporation with headquarters located at 50 West 23rd Street, New York, New York 10010 (the “Company”), and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 26th, 2012 • Nupathe Inc. • Pharmaceutical preparations • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 25, 2012, by and among NuPathe Inc., a Delaware corporation with headquarters located at 227 Washington Street, Suite 200, Conshohocken, Pennsylvania 19428 (the “Company”), and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 30th, 2012 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 29, 2012, by and among ACELRX PHARMACEUTICALS, INC., a Delaware corporation with headquarters located at 575 Chesapeake Drive, Redwood City, CA 94063 (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 19th, 2010 • Kinderhook Partners, Lp • Retail-drug stores and proprietary stores • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 8, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation with headquarters located at 2979 SE Gran Park Way, Stuart, Florida 34997 (the “Company”), and Kinderhook Partners, L.P. (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2010 • Liberator Medical Holdings, Inc. • Retail-drug stores and proprietary stores • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 9, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation with headquarters located at 2979 SE Gran Park Way, Stuart, Florida 34997 (the “Company”), and Kinderhook Partners, L.P. (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 30th, 2009 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 14th, 2008 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of July 9, 2008, by and among Threshold Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 1300 Seaport Boulevard, Redwood City, CA 94063 (the “Company”), and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 23rd, 2007 • Intelligentias, Inc. • Services-business services, nec • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), is dated as of October 19, 2007, by and among Intelligentias, Inc., a Nevada corporation (the “Company”) and the investors listed on Exhibit A hereto (each an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 21st, 2007 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 3rd, 2007 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 29, 2007, by and among VIA Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 750 Battery Street, Suite 330, San Francisco, CA 94111 (the “Company”), and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 7th, 2007 • Silicom LTD • Computer communications equipment
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 3, 2007, by and among Silicom Ltd., an Israeli corporation with headquarters located at 8 Hanagar Street, Kfar Sava 44000, Israel (the “Company”), and CD Investment Partners, Ltd. (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 7th, 2007 • Silicom LTD • Computer communications equipment
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 3, 2007, by and among Silicom Ltd., an Israeli corporation with headquarters located at 8 Hanagar Street, Kfar Sava 44000, Israel (the “Company”), and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and collectively, the “Investors”).
